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Neomycin and lactulose are thought to exert their influence on
hepatic coma exclusively by interfering with the bacterial flora, but
our results suggest a potential additional effect, namely interference
with glutamine-dependent non-bacterial ammonia production.9
This glutamine-dependent ammonia production may exceed by far
the bacterial ammonia production. We suggest that the mechanism
of action of lactulose and neomycin will be better understood when
, 
the potential influence of these compounds on non-bacterial
ammonia generation is taken into account.
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ANTIBODIES TO PLASMID-ENCODED PROTEINS
OF ENTEROPATHOGENIC YERSINIA IN PATIENTS
WITH AUTOIMMUNE THYROID DISEASE
SIR,-Bech et all have suggested an association between thyroid
autoimmune disorders and humoral1,3 and cellular immunity to
Yersinia enterocolitica. Binding sites for thyrotropin have also been
described.’ The role of Yersinia in the pathogenesis of thyroid
autoimmune disorders is not, however, understood, partly because
most studies were done with laboratory strains of Y enterocolitica of
different serotypes that had lost their virulence. A pre-requisite to
virulence of the most common enteropathogenic Y enterocolitica
and Y pseudotuberculosis strains is the presence of a 42-46 MD
plasmid which is rapidly lost after subcultivation.5 Virulence in
terms of serum resistance, phagocytosis resistance, and cell
adherence is mediated by these plasmids.6,7 These plasmids also
encode for at least six proteins against which man and animals
produce antibodies after Yersinia infection.8,9 In calcium-deficient
nutrient broth virulent Yersinia release strongly immunogenic
proteins in large quantities.6,g By sodium dodecyl sulphate/
polyacrylamide gel electrophoresis bands of released proteins (RPs)
can be seen at 25 kD, 34 kD (Y pseudotuberculosis)/36 kD (Y
enterocolitica), 38 kD, 46 kD, and 58 kD (Y enterocolitica)/67 kD (Y
pseudotuberculosis).
We have investigated sera from patients with thyroid
autoimmune disorders for antibodies to RPs and studied the
prevalence of specific immunoglobulin classes by western blotting.
The occurrence of RPmtibodies in 336 healthy blood-donors and
28 patients with non-toxic goitre was compared with that in 100
patients with Graves’ disease and 38 patients with Hashimoto’s
thyroiditis. All Graves’ disease patients were hyperthyroid and had
TSH-receptor antibodies. The onset of Graves’ disease was
estimated at admission by the patient’s report of symptoms of
hyperthyroidism. Patients with Hashimoto’s thyroiditis had been
receiving thyroxine for 1-7 years. No patient with a non-toxic goitre
had thyroid antiboides. No abnormal frequencies of Yersinia
infections were reported during the study.
Sera from patients with Graves’ disease or Hashimoto’s
thyroiditis had increased frequencies of RP antibodies of either
Ig-class compared with controls (table). The manifestation of IgA
antibodies to RPs indicates a recent or persistent yersiniosis.
Antibodies to 25 kD RP are of special interest, because preliminary
results suggest that this antibody shares antigenic epitopes with the
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X2 test, p. t<0’05, &Dagger;<0.01, and &sect;<0-001 compared with blood donors; p<0 05
compared with patients with non-toxic goitre.
TSH receptor." Moreover, antibodies to 25 kD RP are transient,
emerging in the first three months after infection and fading away
after about one year. We observed a similar pattern when patients
with Graves’ disease were grouped according to the onset of
hyperthyroidism. Within one year both 25 kD and IgA antibodies
had reached a peak and decreased in recurrent Graves’ disease. In
most cases the 25 kD antibodies were detected as IgG-class
immunoglobulins. IgG antibodies to RP persist for several years.
Consequently IgG antibodies steadily increased to 81 % in
recurrent Graves’ disease. An ongoing prospective study in newly
diagnosed cases of Graves’ disease confirms these antibody
profiles-ie, no RP antibodies at the time of diagnosis and then IgA,
IgG, and 25 kD RP antibodies developing within eight months.
Thus we have found a strong association between thyroid
autoimmune disease and antibodies against plasmid-encoded
proteins of enteropathogenic Yersinia. Crossreactivity of antibodies
in thyroid autoimmune disease with Y enterocolitica or Y
pseudotuberculosis can now be understood independently of Yersillia
serotypes. In Graves’ disease the binding of thyrotropin in Y
enterocolitica,4 the sharing of epitopes of the Yersinia plasmid with
the thyrotropin receptor, 10 and the plasmid antibody profile that we
have demonstrated indicate antigenic mimicry, which could well
have an initiating role in the disease.
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